{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T16:08:16Z","timestamp":1790611696182,"version":"4.1.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"38","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.vaccine.2023.07.053","type":"journal-article","created":{"date-parts":[[2023,8,4]],"date-time":"2023-08-04T08:43:11Z","timestamp":1691138591000},"page":"5648-5654","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Inactivated SARS-CoV-2 vaccination does not disturb the clinical course of Graves\u2019 disease: An observational cohort study"],"prefix":"10.1016","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5944-8470","authenticated-orcid":false,"given":"Shichen","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huixin","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xian","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiandong","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1740-8833","authenticated-orcid":false,"given":"Li","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2023.07.053_b0005","unstructured":"WHO Coronavirus (COVID-19) Dashboard. https:\/\/covid19.who.int\/. Accessed 20th September 2022."},{"key":"10.1016\/j.vaccine.2023.07.053_b0010","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.phrs.2015.08.003","article-title":"Vaccines, adjuvants and autoimmunity","volume":"100","author":"Guimaraes","year":"2015","journal-title":"Pharmacol Res"},{"issue":"12","key":"10.1016\/j.vaccine.2023.07.053_b0015","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1007\/s00296-021-05017-9","article-title":"Adverse events of six COVID-19 vaccines in patients with autoimmune rheumatic diseases: a cross-sectional study","volume":"41","author":"Esquivel-Valerio","year":"2021","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.vaccine.2023.07.053_b0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2021.102710","article-title":"Autoimmune hepatitis triggered by SARS-CoV-2 vaccination","volume":"123","author":"Vuille-Lessard","year":"2021","journal-title":"J Autoimmun"},{"issue":"10","key":"10.1016\/j.vaccine.2023.07.053_b0025","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2021-244527","article-title":"Guillain-Barre syndrome presenting with facial diplegia following COVID-19 vaccination in two patients","volume":"14","author":"Kanabar","year":"2021","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.vaccine.2023.07.053_b0030","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.728513","article-title":"Pathogenic Mechanisms of Vaccine-Induced Immune Thrombotic Thrombocytopenia in People Receiving Anti-COVID-19 Adenoviral-Based Vaccines: A Proposal","volume":"12","author":"Azzarone","year":"2021","journal-title":"Front Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2023.07.053_b0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.beem.2023.101759","article-title":"COVID-19 vaccination and thyroiditis","volume":"37","author":"Sendur","year":"2023","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.vaccine.2023.07.053_b0040","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1186\/s40001-023-01210-7","article-title":"New-onset and relapsed Graves' disease following COVID-19 vaccination: a comprehensive review of reported cases","volume":"28","author":"Chen","year":"2023","journal-title":"Eur J Med Res"},{"issue":"4","key":"10.1016\/j.vaccine.2023.07.053_b0045","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1089\/thy.2019.0067","article-title":"Efficacy and Safety of Long-Term Universal Salt Iodization on Thyroid Disorders: Epidemiological Evidence from 31 Provinces of Mainland China","volume":"30","author":"Li","year":"2020","journal-title":"Thyroid"},{"issue":"16","key":"10.1016\/j.vaccine.2023.07.053_b0050","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1056\/NEJMra1510030","article-title":"Graves' Disease","volume":"375","author":"Smith","year":"2016","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.vaccine.2023.07.053_b0055","doi-asserted-by":"crossref","first-page":"6320","DOI":"10.4049\/jimmunol.170.12.6320","article-title":"Chemokines determine local lymphoneogenesis and a reduction of circulating CXCR4+ T and CCR7 B and T lymphocytes in thyroid autoimmune diseases","volume":"170","author":"Armengol","year":"2003","journal-title":"J Immunol"},{"issue":"10","key":"10.1016\/j.vaccine.2023.07.053_b0060","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1080\/14760584.2019.1674144","article-title":"How vaccines work: immune effector mechanisms and designer vaccines","volume":"18","author":"Sell","year":"2019","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2023.07.053_b0065","article-title":"The Effect of Inactivated SARS-CoV-2 Vaccines on TRAB in Graves' Disease","volume":"13","author":"Huang","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"10","key":"10.1016\/j.vaccine.2023.07.053_b0070","first-page":"6","article-title":"Guidelines for diagnosis and management of thyroid diseases in China","volume":"46","author":"Chinese Society of Endocrinology","year":"2007","journal-title":"Zhong Hua Nei Ke Za Zhi"},{"issue":"10","key":"10.1016\/j.vaccine.2023.07.053_b0075","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1089\/thy.2016.0229","article-title":"2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis","volume":"26","author":"Ross","year":"2016","journal-title":"Thyroid"},{"issue":"6","key":"10.1016\/j.vaccine.2023.07.053_b0080","doi-asserted-by":"crossref","first-page":"e2324","DOI":"10.1210\/clinem\/dgac119","article-title":"SARS-CoV-2 mRNA Vaccination and Graves' Disease: A Report of 12 Cases and Review of the Literature","volume":"107","author":"Chee","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"10.1016\/j.vaccine.2023.07.053_b0085","article-title":"Graves\u2019 Disease Following SARS-CoV-2 Vaccination: A Systematic Review","volume":"10","author":"Patrizio","year":"2022","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.vaccine.2023.07.053_b0090","doi-asserted-by":"crossref","unstructured":"Cohen Tervaert J. W., Martinez-Lavin M., Jara L. J., Halpert G., Watad A., Amital H., Shoenfeld Y. Autoimmune\/inflammatory syndrome induced by adjuvants (ASIA) in 2023. Autoimmun Rev. 2023;22(5):103287.","DOI":"10.1016\/j.autrev.2023.103287"},{"issue":"2","key":"10.1016\/j.vaccine.2023.07.053_b0095","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.vaccine.2020.12.009","article-title":"Individual preferences for COVID-19 vaccination in China","volume":"39","author":"Leng","year":"2021","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2023.07.053_b0100","doi-asserted-by":"crossref","first-page":"757","DOI":"10.3803\/EnM.2021.404","article-title":"Committee of Clinical Practice Guideline of the Korean Endocrine Society. COVID-19 Vaccination for Endocrine Patients: A Position Statement from the Korean Endocrine Society","volume":"36","author":"Ku","year":"2021","journal-title":"Endocrinol Metab (Seoul)"},{"key":"10.1016\/j.vaccine.2023.07.053_b0105","unstructured":"Anton Luger Andrea Giustina, Robin Peeters. European Society of Endocrinology (ESE)\u2019s statement concerning COVID-19 vaccination: \u2018follow the same recommendations for patients with stable endocrine disorders as for the general population\u2019. 20https:\/\/www.ese-hormones.org\/news\/ese-news\/european-society-of-endocrinology-ese-s-statement-concerning-covid-19-vaccination-follow-the-same-recommendations-for-patients-with-stable-endocrine-disorders-as-for-the-general-population\/. Accessed 26th July 2022."},{"key":"10.1016\/j.vaccine.2023.07.053_b0110","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2021.778964","article-title":"Development of Graves' Disease After SARS-CoV-2 mRNA Vaccination: A Case Report and Literature Review","volume":"9","author":"Lui","year":"2021","journal-title":"Front Public Health"},{"issue":"5","key":"10.1016\/j.vaccine.2023.07.053_b0115","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1089\/thy.2021.0684","article-title":"Safety of Inactivated and mRNA COVID-19 Vaccination Among Patients Treated for Hypothyroidism: A Population-Based Cohort Study","volume":"32","author":"Xiong","year":"2022","journal-title":"Thyroid"},{"issue":"5","key":"10.1016\/j.vaccine.2023.07.053_b0120","doi-asserted-by":"crossref","first-page":"e76","DOI":"10.1210\/clinem\/dgac684","article-title":"Effect of Inactivated and mRNA COVID-19 Vaccination on Thyroid Function Among Patients Treated for Hyperthyroidism","volume":"108","author":"Wong","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.vaccine.2023.07.053_b0125","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1186\/s12916-022-02548-1","article-title":"Risk of thyroid dysfunction associated with mRNA and inactivated COVID-19 vaccines: a population-based study of 2.3 million vaccine recipients","volume":"20","author":"Wong","year":"2022","journal-title":"BMC Med"},{"issue":"9","key":"10.1016\/j.vaccine.2023.07.053_b0130","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1089\/thy.2022.0101","article-title":"Effect of Inactivated SARS-CoV-2 Vaccine on Thyroid Function and Autoimmunity Within 28 Days After the Second Dose","volume":"32","author":"Li","year":"2022","journal-title":"Thyroid"},{"issue":"9","key":"10.1016\/j.vaccine.2023.07.053_b0135","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1089\/thy.2020.0881","article-title":"Does Age or Sex Relate to Severity or Treatment Prognosis in Graves' Disease?","volume":"31","author":"Suzuki","year":"2021","journal-title":"Thyroid"},{"key":"10.1016\/j.vaccine.2023.07.053_b0140","doi-asserted-by":"crossref","first-page":"1027047","DOI":"10.3389\/fendo.2022.1027047","article-title":"Endocrine system after 2 years of COVID-19 vaccines: A narrative review of the literature","volume":"13","author":"Pezzaioli","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"10","key":"10.1016\/j.vaccine.2023.07.053_b0145","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1007\/s40618-022-01786-7","article-title":"Thyroid dysfunction following vaccination with COVID-19 vaccines: a basic review of the preliminary evidence","volume":"45","author":"Jafarzadeh","year":"2022","journal-title":"J Endocrinol Invest"},{"issue":"1","key":"10.1016\/j.vaccine.2023.07.053_b0150","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/s40249-021-00915-3","article-title":"Effectiveness and safety of SARS-CoV-2 vaccine in real-world studies: a systematic review and meta-analysis","volume":"10","author":"Liu","year":"2021","journal-title":"Infect Dis Poverty"},{"key":"10.1016\/j.vaccine.2023.07.053_b0155","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2022.829176","article-title":"Safety, Immunogenicity, and Efficacy of COVID-19 Vaccines in Adolescents, Children, and Infants: A Systematic Review and Meta-Analysis","volume":"10","author":"Du","year":"2022","journal-title":"Front Public Health"},{"issue":"10","key":"10.1016\/j.vaccine.2023.07.053_b0160","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1080\/14760584.2022.2104714","article-title":"Neutralizing antibodies and cellular immune response after two doses of inactivated SARS-CoV-2 vaccine in China","volume":"21","author":"Yan","year":"2022","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2023.07.053_b0165","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ijid.2022.05.007","article-title":"Evaluation of long-term antibody kinetics in healthcare workers vaccinated with inactivated COVID-19 Vero cell vaccine (CoronaVac), a propensity score-matched observational study","volume":"122","author":"Yildiz","year":"2022","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.vaccine.2023.07.053_b0170","article-title":"Temporal changes in factors associated with COVID-19 vaccine hesitancy and uptake among adults in Hong Kong: Serial cross-sectional surveys","volume":"23","author":"Xiao","year":"2022","journal-title":"Lancet Reg Health West Pac"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X23008848?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X23008848?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:31:30Z","timestamp":1759404690000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X23008848"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":34,"journal-issue":{"issue":"38","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["S0264410X23008848"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2023.07.053","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inactivated SARS-CoV-2 vaccination does not disturb the clinical course of Graves\u2019 disease: An observational cohort study","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2023.07.053","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}